Becton Dickinson and Co (BDX)
6 Dec 2013
|Market Cap (Mil.):||$21,030.13|
|Shares Outstanding (Mil.):||194.09|
- Medical technology company Becton Dickinson & Co said on Tuesday that quarterly net income fell as costs rose sharply, but after excluding litigation charges and pension settlements, the results were higher than analysts had expected.
Nov 5 - Medical technology company Becton Dickinson & Co said on Tuesday that quarterly net income fell as costs rose sharply, but after excluding litigation charges and pension settlements, the results were higher than analysts had expected.
Sept 20 - Becton Dickinson and Co said it may have to pay up to $340 million after a federal jury found the medical device maker guilty of attempting to monopolize the safety syringe market through deceptive practices.
|Baxter International Inc. (BAX.N)||$67.48||+0.78|
|Covidien plc (COV.N)||$67.31||-0.18|
|Stryker Corporation (SYK.N)||$74.34||+1.18|
|Boston Scientific Corporation (BSX.N)||$11.85||+0.51|
|C.R. Bard, Inc. (BCR.N)||$137.44||+0.82|
|Hologic, Inc. (HOLX.OQ)||$22.30||-0.17|
|Quidel Corporation (QDEL.OQ)||$24.28||+0.15|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (BDX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: Pechala's Reports
Becton Dickinson and Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Validea Guru Analysis Report for BDX. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.